Precision and immediacy – one step ahead with IORT during tumor resection
ZEISS INTRABEAM Spherical Applicator
The ZEISS INTRABEAM Spherical Applicator can be used for the intracavitary intraoperative delivery of radiation to the tumor bed, e.g. at the time of breast conserving surgery.
ZEISS INTRABEAM Needle Applicator
The ZEISS INTRABEAM Needle Applicator can be used for the interstitial irradiation of tumors, e.g. in the treatment of vertebral metastases or brain tumors.
ZEISS INTRABEAM Flat Applicator
The ZEISS INTRABEAM Flat Applicator can be used for the treatment of the tumor bed on surgically exposed surfaces, e.g. tumors of the gastrointestinal tract.
ZEISS INTRABEAM Surface Applicator
The ZEISS INTRABEAM Surface Applicator can be used in the treatment of the tumor bed on the surface of the body, for example, irradiation of non-melanoma skin cancers.
Time matters
Immediate irradiation during surgery in the OR prevents tumor reformation stimulated by wound healing after resection3,4 and can lead to shorter overall treatments. This efficiently saves hospital time without compromising outcomes and lets patients benefit from a completed treatment while sleeping.5
Shorter overall treatments
Post-operative treatment times of up to 6.5 weeks can be reduced to 3-5 weeks or even be eliminated for selected patients when adding IORT during breast-conserving surgery (BCS).
Proven performance
ZEISS INTRABEAM devices have an extensive record of +250 peer-reviewed publications and +20 studies from over 30 countries confirming the clinical value of personalized and patient-centric IORT treatment options. This helps you to meet future clinical demands and secure reimbursements – a primary aspect of successful healthcare management in the future.